In vivo studies on receptor pharmacology of the human eccrine sweat gland
- 99 Downloads
The receptor pharmacology of the human sweat gland was studiedin vivo. The axon-reflex response was mediated by nicotinic receptors which were activated by nicotine and acetylcholine, but not pilocarpine, and inhibited by hexamethonium. The direct response was mainly muscarinic, responding to pilocarpine and acetylcholine. A component of the direct response was nicotinic, since it was activated by nicotine and blocked by hexamethonium in a dose-dependent manner. The axon-reflex response to nicotine and acetylcholine was partially blocked by pilocarpine, especially when application of pilocarpine preceded the procedure. The inhibition of the nicotinic response may be secondary to M1 antagonism since pilocarpine is an M2 agonist and M1 antagonist and pirenzepine, a specific M1 antagonist, caused similar effects as pilocarpine.
Key wordsSweat gland Muscarinic Nicotinic Receptor
Unable to display preview. Download preview PDF.
- 1.Coon JM, Rothman S. The sweat response to drugs with nicotine-like action.J Pharmacol 1941;73: 1–11.Google Scholar
- 4.Winslow CEA, Herrington LP, Gagge AP. Physiologic reactions of the human body to varying environmental temperatures.Am J Physiol 1937;120: 1–22.Google Scholar
- 6.Chelimsky TC, Low PA. Pharmacology of the sudomotor axon reflex.Neurology 1988;38: 224A.Google Scholar
- 8.McKinney M, Stenstrom S, Richelson E. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115).Molec Pharmacol 1985;27: 223–235.Google Scholar
- 11.Wallin BG. Peripheral sympathetic neural activity in conscious humans.Ann Rev Physiol 1988;50: 565–576.Google Scholar
- 14.Uno H, Montagna W. Catecholamine-containing nerve terminals of the eccrine sweat glands of macaques.Cell Tiss Res 1975;158: 1–13.Google Scholar